Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Lonza Group AG

Capitalization 34.03B 43.38B 37.63B 32.49B 59.09B 4,005B 61.16B 405B 161B 1,914B 163B 159B 6,907B P/E ratio 2025
39.8x
P/E ratio 2026 * 29.5x
Enterprise value 37.49B 47.8B 41.46B 35.8B 65.11B 4,413B 67.39B 446B 177B 2,109B 179B 176B 7,610B EV / Sales 2025
6.28x
EV / Sales 2026 * 5.22x
Free-Float
93.86%
Yield 2025
0.93%
Yield 2026 * 1.12%

Last Transcript: Lonza Group AG

1 day-0.46%
1 week-4.46%
Current month-10.16%
1 month-7.54%
3 months-7.93%
6 months-11.97%
Current year-10.43%
1 week 478.7
Extreme 478.7
509.6
1 month 478.7
Extreme 478.7
542.4
Current year 478.7
Extreme 478.7
585.6
1 year 467.8
Extreme 467.8
605.2
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 152.8
Extreme 152.8
785.4
Manager TitleAgeSince
Chief Executive Officer 54 30/06/2024
Director of Finance/CFO 54 30/11/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 15/04/2014
Director/Board Member 68 15/04/2014
Director/Board Member 66 25/04/2016
Change 5d. change 1-year change 3-years change Capi.($)
-0.46%-4.46%-10.90%-8.42% 43.38B
-4.55%-2.61%+14.19%+31.94% 31.64B
-1.44%-2.60%+14.63%+45.41% 30.26B
-5.04%-8.72%-12.13%-17.40% 27.35B
-4.54%-4.59%+142.53%+357.95% 18.84B
+0.66%-3.51%+52.36%+115.62% 14.06B
-7.09%-5.44%+36.61%+153.01% 12.6B
-0.32%-4.80%+21.98%-2.54% 12.52B
-3.28%-3.75%+116.52%+113.02% 11.95B
+1.44%-0.87%+21,619.46%+3,341.35% 11.87B
Average -2.46%-4.45%+2,199.53%+412.99% 21.45B
Weighted average by Cap. -2.50%-4.68%+1,222.67%+246.26%

Financials

2025 2026 *
Net sales 7.57B 9.65B 8.37B 7.22B 13.14B 891B 13.6B 90.05B 35.76B 426B 36.2B 35.43B 1,536B 7.14B 9.1B 7.9B 6.82B 12.4B 840B 12.83B 84.96B 33.74B 402B 34.16B 33.43B 1,449B
Net income 1.03B 1.31B 1.14B 980M 1.78B 121B 1.85B 12.22B 4.85B 57.73B 4.91B 4.81B 208B 1.17B 1.49B 1.3B 1.12B 2.03B 138B 2.1B 13.94B 5.53B 65.86B 5.6B 5.48B 238B
Net Debt 3.46B 4.42B 3.83B 3.31B 6.01B 408B 6.22B 41.22B 16.37B 195B 16.57B 16.22B 703B 3.23B 4.12B 3.58B 3.09B 5.62B 381B 5.81B 38.49B 15.28B 182B 15.47B 15.14B 656B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
19,771
Date Price Change Volume
13/03/26 483.80 CHF -0.14% 50,393
12/03/26 484.50 CHF -1.04% 145,875
11/03/26 489.60 CHF -1.39% 201,508
10/03/26 496.50 CHF -0.44% 127,275
09/03/26 498.70 CHF -1.09% 193,292
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
484.50CHF
Average target price
675.78CHF
Spread / Average Target
+39.48%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW